Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Labonté, Marie Ève ^a   Couture, Patrick ^a   Tremblay, André J ^a   Hogue, Jean Charles ^a   Lemelin, Valéry ^b   Lamarche, Benoît ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Docosahexaenoic acid (DHA); Duodenum; Eicosapentaenoic acid (EPA); Inflammatory gene expression; n 3 supplementation; Placebo controlled; Signal transducer and activator of transcription 3 (STAT3); Type 2 diabetes

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; INTERLEUKIN 18; INTERLEUKIN 6; MESSENGER RNA; PLACEBO; SOYBEAN OIL; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; STAT3 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DUODENUM; DUODENUM BIOPSY; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTESTINE; MAIZE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; ADOLESCENT; BLOOD; BODY MASS; COMPLICATION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; YOUNG ADULT;

GLYCINE MAX; ZEA MAYS;

ADOLESCENT; ADULT; BODY MASS INDEX; CHOLESTEROL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DUODENUM; EICOSAPENTAENOIC ACID; FISH OILS; GENE EXPRESSION REGULATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; OBESITY; QUESTIONNAIRES; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84880118116     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-98     Document Type: Article

References (22)

1. Obesity, metalic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Pradhan A, Nutr Rev 2007 65 152 S156 10.1301/nr.2007.dec.S152-S156 18240540
2. Increased Adipose-tissue expression of tumor-necrosis-factor-alpha in human obesity and insulin-resistance. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM, J Clin Invest 1995 95 2409 2415 10.1172/JCI117936 7738205
3. Resolution of adipose tissue inflammation. Gonzalez-Periz A, Claria J, ScientificWorldJournal 2010 10 832 856 20454765
4. Role of intestinal inflammation as an early event in obesity and insulin resistance. Ding S, Lund PK, Curr Opin Clin Nutr Metab Care 2011 14 328 333 10.1097/MCO.0b013e3283478727 21587067
5. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Bouwens M, van de Rest O, Dellschaft N, Bromhaar MG, de Groot LCPG, Geleijnse JM, Muller M, Afman LA, Am J Clin Nutr 2009 90 415 424 10.3945/ajcn.2009.27680 19515734
6. Stearidonic and Eicosapentaenoic acids inhibit interleukin-6 expression in ob/ob mouse adipose stem cells via toll-like receptor-2-mediated pathways. Hsueh HW, Zhou Z, Whelan J, Allen KGD, Moustaid-Moussa N, Kim H, Claycombe KJ, J Nutr 2011 141 1260 1266 10.3945/jn.110.132571 21562237
7. n-3 PUFA: bioavailability and modulation of adipose tissue function. Kopecky J, Rossmeisl M, Flachs P, Kuda O, Brauner P, Jilkova Z, Stankova B, Tvrzicka E, Bryhn M, Proc Nutr Soc 2009 68 361 369 10.1017/S0029665109990231 19698199
8. Effect of marine n-3 fatty acids on circulating inflammatory markers in healthy subjects and subjects with cardiovascular risk factors. Myhrstad MCW, Retterstol K, Telle-Hansen VH, Ottestad I, Halvorsen B, Holven KB, Ulven SM, Inflamm Res 2011 60 309 319 10.1007/s00011-010-0302-5 21229287
9. Follow-up report on the diagnosis of diabetes mellitus. Genuth S, Alberti KGMM, Bennett P, Buse J, DeFronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Diabetes Care 2003 26 3160 3167 14578255 (Pubitemid 37339514)
10. Lipoprotein-cholesterol distributions in selected north-American populations-lipid research clinics program prevalence study. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkind BM, Schonfeld G, Jacobs D, Frantz ID, Circulation 1980 61 302 315 10.1161/01.CIR.61.2.302 7351055 (Pubitemid 10214988)
11. Executive Summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). NCEP Expert Panel, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
12. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S, Nutr J 2004 3 13 10.1186/1475-2891-3-13 15363100
13. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Frasure-Smith N, Lesperance F, Julien P, Biol Psychiatry 2004 55 891 896 10.1016/j.biopsych.2004.01.021 15110732 (Pubitemid 38526301)
14. Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR, Couture P, J Lipid Res 2011 52 558 565 10.1194/jlr.M011080 21123766
15. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Luu-The V, Paquet N, Calvo E, Cumps J, Biotechniques 2005 38 287 293 10.2144/05382RR05 15727135 (Pubitemid 40216386)
16. Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M, Physiol Genomics 2000 2 143 147 11015593
17. Is Crohn's creeping Fat an adipose tissue? Olivier I, Theodorou V, Valet P, Castan-Laurell I, Guillou H, Bertrand-Michel J, Cartier C, Bezirard V, Ducroc R, Segain JP, Portier G, Kirzin S, Moreau J, Duffas JP, Ferrier L, Eutamene H, Inflamm Bowel Dis 2011 17 747 757 10.1002/ibd.21413 20684014
18. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, Muller-Alouf H, Hafraoui S, Emilie D, Ectors N, Peuchmaur M, Cortot A, Capron M, Auwerx J, Colombel JF, Gastroenterology 1999 117 73 81 10.1016/S0016-5085(99)70552-4 10381912 (Pubitemid 29297622)
19. Impact of dietary fat on Th1/Tk2 cytokine gene expression in the pancreas and gut of diabetes-prone BB rats. Kleemann R, Scott FW, Worz-Pagenstert U, Ratnayake WMN, Kolb H, J Autoimmun 1998 11 97 103 10.1006/jaut.1997.0179 9480727 (Pubitemid 28080732)
20. Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. van Schothorst EM, Flachs P, Franssen-van Hal NLW, Kuda O, Bunschoten A, Molthoff J, Vink C, Hooiveld GJEJ, Kopecky J, Keijer J, BMC Genomics 2009 10 110 10.1186/1471-2164-10-110 19284886
21. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Calder PC, Mol Nutr Food Res 2008 52 885 897 10.1002/mnfr.200700289 18504706
22. Increased Consumption of fatty and lean fish reduces serum C-reactive protein concentrations but Not inflammation markers in feces and in colonic biopsies. Pot GK, Geelen A, Majsak-Newman G, Harvey LJ, Nagengast FM, Witteman BJM, van de Meeberg PC, Hart AR, Schaafsma G, Lund EK, Rijkers GI, Kampman E, J Nutr 2010 140 371 376 10.3945/jn.109.113472 20032491